利用专利数据评估医药创新的价值。

Using patent data to assess the value of pharmaceutical innovation.

机构信息

Department of Health Policy and Management, Harvard School of Public Health, Harvard Medical School, USA.

出版信息

J Law Med Ethics. 2009 Summer;37(2):176-83. doi: 10.1111/j.1748-720X.2009.00364.x.

DOI:10.1111/j.1748-720X.2009.00364.x

PMID:19493065

Abstract

Though many more patents emerge from industry sources, drug-related patents generated in the non-profit setting appear to have greater importance than patents arising from the commercial sector, which helps demonstrate the value non-profit research institutions can have in driving drug development.

摘要

尽管来自工业界的专利申请更多，但非营利性机构产生的与药物相关的专利似乎比商业部门产生的专利更为重要，这有助于证明非营利研究机构在推动药物研发方面的价值。